Literature DB >> 8992086

[Indications for eye examination of HIV patients--screening parameters for cytomegalovirus retinitis].

M M Gellrich1, W D Lagrèze, J A Rump, L L Hansen.   

Abstract

BACKGROUND: To reduce the burden of frequent visits at the physician we have checked (I) for which ocular manifestations in HIV-infection screening of asymptomatic patients is worthwhile and (II) which parameters may indicate patients at risk for CMV-retinitis. PATIENTS AND METHODS: The clinical data of 215 HIV-infected patients were analyzed retrospectively. Only those ocular manifestations were considered suitable for screening that (a) endanger vision, (b) are treatable, (c) can be diagnosed sufficiently early and (d) are common. Furthermore (1) CDC-stage, (2) CD4+ count, (3) HIV-retinopathy, (4) CMV-uria and (5) CMV-antibodies were checked for their usefulness in indicating patients at risk for CMV-retinitis.
RESULTS: Ophthalmological screening of asymptomatic HIV-patients should focus on cytomegalovirus (CMV)-retinitis because early diagnosis of this common blinding disease improves the visual outcome. 85 of 215 HIV-infected patients had a CD4+ count less than 50 cells/microliters 25% of these patients developed CMV-retinitis (21/85). The risk for CMV-retinitis rose to 38% (13/34) when the low CD4+ count was accompanied by CMV-uria. The proportion of patients with CMV-retinitis did not increase when HIV-retinopathy had been diagnosed earlier (12/48 = 25%). CMV-serology and CDC-classification were not helpful in screening for CMV-retinitis.
CONCLUSIONS: We recommend the following ophthalmological screening scheme for HIV-patients without ocular symptoms: (1) patients with a CD4+ count < 100 cells/microliters should be checked every third month and (2) those with a CD4+ count < 50 cells/microliters and CMV-uria every sixth week.

Entities:  

Mesh:

Year:  1996        PMID: 8992086     DOI: 10.1055/s-2008-1035281

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  3 in total

1.  CMV retinitis in China and SE Asia: the way forward.

Authors:  David Heiden; Peter Saranchuk
Journal:  BMC Infect Dis       Date:  2011-11-24       Impact factor: 3.090

2.  Training clinicians treating HIV to diagnose cytomegalovirus retinitis.

Authors:  David Heiden; NiNi Tun; Ernest Maningding; Matthew Heiden; Jennifer Rose-Nussbaumer; Khin Nyein Chan; Tamara Khizniak; Alexandra Yakubenko; Susan Lewallen; Jeremy D Keenan; Peter Saranchuk
Journal:  Bull World Health Organ       Date:  2014-09-22       Impact factor: 9.408

3.  Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic.

Authors:  David Heiden; Nathan Ford; David Wilson; William R Rodriguez; Todd Margolis; Bart Janssens; Martha Bedelu; Nini Tun; Eric Goemaere; Peter Saranchuk; Kalpana Sabapathy; Frank Smithuis; Emmanuel Luyirika; W Lawrence Drew
Journal:  PLoS Med       Date:  2007-12       Impact factor: 11.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.